World Pharma News

Home News Channels Contact Us Search XING Forums Members Login

Conferences & Events Cellular Imaging & Analysis 2008 Event by European Pharmaceutical Review Sales Force Effectiveness Russia-CIS Strategic Marketing and Branding for the Pharmaceutical Industry Workshop on molecular targets for cancer, Bergen, Norway	Research & Development First call for Innovative Medicines Initiative a success GlaxoSmithKline teams up with academia to develop new medicines of value New FP7 eHealth Project - preDiCT BASF and Transinsight agree to collaborate in exploring alternatives to animal testing
Read more...	Read more...

Welcome

World Pharma News is an ambitious online news service dedicated to the world pharmaceutical industry. Our main goal is to keep our readers informed about the latest worldwide pharmaceutical news, realizations and achievements.

Register now to be in touch with our last developments and achievements or Subscribe to World Pharma News alerts by Email (a free service delivered by FeedBurner).

Non progredi est regredi.

World Pharma News .net

Explore the first worldwide Web 2.0 pharmaceutical news portal and 'Vote', 'Comment' or 'Submit' pharmaceutical news articles or other pharmaceutical web resources!
For further information, please visit http://www.worldpharmanews.net

Get all news digests delivered to your inbox, subscribe to World Pharma News Google Group.

Email:

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]

Pharmaceutical RSS News

Start your day with worldwide pharmaceutical

news
[ Amgen | AstraZeneca | Boehringer Ingelheim | Bristol-Myers Squibb | GlaxoSmithKline | Janssen-Cilag | Johnson & Johnson | Novartis | Novo Nordisk | Pfizer | Roche | Shire | Takeda ]

European Commission

European Commission - Pharmaceuticals
FDA

FDA

US Food and Drug Administration

Sponsored Ads

Sponsored Ads

World Pharma News .net / Published News

Our RSS News Channels

ATOM 0.3

OPML

Sponsored Ads

Roche Media News

The latest media news from Roche

Statement - Roche has not incorporated "a molecule" into Mircera
Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
Roche and ARIUS Research Inc. today announced that the two companies have signed a definitive agreement for Roche to acquire ARIUS in an all-cash transaction at a price of approximately C$191 million. ARIUS is the developer of a proprietary antibody platform called FunctionFIRST, which rapidly identifies and selects antibodies based on their functional ability to affect disease before progressing into clinical development.
Roche acquires Mirus to advance research in the field of RNAi delivery
Roche and Mirus Bio Corporation announced today that they have entered into a definitive agreement under which Roche will acquire Mirus Bio Corporation, a privately-owned US company based in Madison, Wisconsin, that focuses on the discovery and development of innovative nucleic acid based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform.
Roche posts very good results: strong market outperformance - guidance confirmed
Group sales increase 10% in local currencies (excluding Tamiflu pandemic sales) to 22 billion Swiss francs(+1% in Swiss francs; +18% in US dollars).
Roche makes offer to acquire all outstanding shares of Genentech for US $89.00 per share in cash
Combination to enhance innovation by allowing for diversity of research approaches while also encouraging sharing of IP, technologies, partnerships and other key assets
European approval for Roche`s Pegasys personalises treatment for a subgroup of hepatitis C patients: chance for cure with only four months of treatment
Roche announced today that the European Commission has approved a shortened, 16-week course of treatment with Pegasys (peginterferon alfa-2a (40 KD)) plus Copegus (ribavirin) for certain hepatitis C patients.

Submit to World Pharma News .net

Sponsored Ads

↑ Grab this Headline Animator

Product Patients More Likely to Stay on Lipitor Than Simvastatin, a Large Observational Study Shows GlaxoSmithKline responds to FDA on Cervarix� and plans to submit final study data for approval Cervarix�, GSK's cervical cancer vaccine, wins tender for UK national immunisation programme Genzyme Files Applications for Approval of Mozobil in the United States and Europe Romiplostim Data Show Potential Long-Term Efficacy and Safety	Clinical Trials Novo Nordisk and Neose announce completion of initial phase 1 clinical trial of NN7128 Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR Lapatinib (Tykerb/Tyverb) to be investigated in landmark early breast cancer trial Boehringer Ingelheim announces commitment to progressing science with the Bouquet Studies International study to evaluate efficacy and safety in treating a leading cause of blindness	Corporate Boehringer Ingelheim FENS Award for exceptional research in neuroscience Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case Summary Judgment Granted for SEROQUEL Patent Litigation in the US Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development Abbott and Partnership for a Drug-Free America Launch 'Not In My House'	Financial Pfizer Reports Second-Quarter 2008 Results Novartis gains momentum with strong performance in first half of 2008 Abbott Reports Stronger-than-Expected Sales and Earnings Growth in Second Quarter Novartis completes acquisition of 25% stake in Alcon from Nestl� Shire proposes acquisition of Jerini AG for an equity purchase price of �328 million
Read more...	Read more...	Read more...	Read more...

© World Pharma News - All rights reserved. Terms and Conditions | Contact Us